Get answers for your health queries from top Doctors for FREE!

100% Privacy Protection

100% Privacy Protection

We maintain your privacy and data confidentiality.

Verified Doctors

Verified Doctors

All Doctors go through a stringent verification process.

Quick Response

Quick Response

All Doctors go through a stringent verification process.

Reduce Clinic Visits

Reduce Clinic Visits

Save your time and money from the hassle of visits.

Ask Free Question

  1. Home >
  2. Blogs >
  3. Triple-Negative Breast Cancer Recurrence after Mastectomy
  • Cancer

Triple-Negative Breast Cancer Recurrence after Mastectomy

By Shristi Pardeshi| Last Updated at: 29th Oct '24| 16 Min Read

Overview

Triple-Negative Breast Cancer

Breast cancer is a major health issue for women around the world, and one of the toughest forms is triple-negative breast cancer (TNBC). TNBC is aggressive and does not respond to hormonal treatments that work for other breast cancer types. Even after a mastectomy, which is the surgical removal of the breast, there is still a risk that this cancer can come back.

Recent statistics show that in India, breast cancer is the most common cancer among women, accounting for about 27% of all cancer cases. Globally, approximately 15% of breast cancers diagnosed are triple-negative, making it a significant concern for many women facing this diagnosis.

What Is Triple-Negative Breast Cancer?

Triple-negative breast cancer is a type of breast cancer that does not have three common receptors known to fuel most breast cancers: estrogen, progesterone, and HER2. Since it doesn’t have these receptors, it doesn’t respond to hormonal therapies or HER2-targeted treatments that are effective for other breast cancers. This makes TNBC more difficult to treat and more likely to recur after treatment.

So, what factors contribute to this recurrence?

Why Does Triple-Negative Breast Cancer Come Back?

While a mastectomy removes the breast tissue, triple-negative breast cancer has a higher chance of coming back compared to other types of breast cancer. There are several reasons why TNBC can recur:

  • Aggressive Nature of TNBC: Triple-negative breast cancer grows and spreads faster than other types of breast cancer. This means that even after surgery, some cancer cells might have spread to other body parts or remained undetected.
  • Limited Treatment Options: Since TNBC doesn’t respond to hormone therapy or targeted HER2 therapies, treatment options are more limited, increasing the risk of recurrence.

Types of Recurrence

There are two main types of recurrence for TNBC:

  1. Local Recurrence: This happens when the cancer comes back in the same area where the breast was removed (the chest wall or nearby lymph nodes).
  2. Distant Recurrence: This occurs when the cancer spreads to other parts of the body, like the bones, lungs, liver, or brain. This is also known as metastatic cancer.

Symptoms of Triple-Negative Breast Cancer Recurrence

The symptoms of a recurrence can vary depending on where the cancer comes back. Here are some common signs to look for:

  • For Local Recurrence: A new lump or swelling in the chest or underarm area, changes in the skin near the mastectomy scar, or a thickening of the tissue near the surgery site.
  • For Distant Recurrence: Symptoms include unexplained weight loss, fatigue, bone pain, shortness of breath, or persistent cough. 

If you experience any of these symptoms, seeing your oncologist is important.

How Is Recurrence Detected?

After a mastectomy, your doctor will monitor your health with regular follow-ups. They may use imaging tests like mammograms, ultrasounds, MRIs, or CT scans to check for signs of recurrence. Blood tests and biopsies may also be used if your doctor suspects the cancer has come back.

Treatment Options for Recurrence

Treatment Options for Recurrence

If triple-negative breast cancer recurs, there are several treatment options depending on the location and severity of the recurrence.

1. Chemotherapy

Chemotherapy is often the first treatment option for TNBC recurrence, especially for distant recurrence. It helps kill cancer cells that may have spread to other parts of the body.

2. Radiation Therapy

If the recurrence is local (in the chest wall or nearby lymph nodes), radiation therapy may be used to target the remaining cancer cells in that area.

3. Immunotherapy

Immunotherapy is a newer option for treating TNBC. It works by boosting your immune system to help it fight cancer more effectively. Drugs like pembrolizumab (Keytruda) may be used in combination with chemotherapy for advanced TNBC.

4. Surgery

In some cases, surgery may be an option to remove a new tumor if the cancer has returned locally. This can be combined with other treatments like radiation or chemotherapy.

5. Clinical Trials

Since triple-negative breast cancer is difficult to treat, many patients opt to join clinical trials that test new drugs or treatment combinations. Your doctor can help you find a trial that may be a good fit for your situation.

Reducing the Risk of Recurrence

Reducing the Risk of Recurrence

While it’s not always possible to prevent TNBC from coming back, there are steps you can take to reduce the risk:

  • Follow-Up Care: Make sure to attend all follow-up appointments with your doctor, who will monitor for any signs of recurrence.
  • Healthy Lifestyle: Maintaining a healthy weight, eating a balanced diet, exercising regularly, and avoiding smoking and excessive alcohol can help reduce the overall risk of cancer.
  • Know the Signs: Be aware of any changes in your body and report new symptoms to your doctor as soon as possible.

If you’re concerned about breast cancer or its recurrence, don't wait, book an appointment with a specialist today for a thorough evaluation.

FAQs 

 1. What are the treatment options for TNBC recurrence?
Treatment options for recurrence include chemotherapyradiation therapyimmunotherapy, and sometimes surgery. In some cases, clinical trials testing new treatments may also be available.

2. What increases the risk of TNBC recurrence after mastectomy?
TNBC is more aggressive and has limited treatment options, which increases the risk of recurrence. Other factors that can increase recurrence risk include large tumor size, lymph node involvement, and incomplete removal of cancerous cells during surgery.

3. Can triple-negative breast cancer recurrence be prevented?
While it’s not possible to completely prevent recurrence, steps like attending regular follow-up appointments, maintaining a healthy lifestyle, and monitoring for symptoms can help reduce the risk and catch recurrence early.

Related Blogs

Question and Answers

. Heterogeneous Soft Tissue Nodule in the Right Lower Lobe (RLL) Size: 14 x 8 mm This nodule is described as heterogeneously enhancing, which suggests it may have varying levels of blood flow or different tissue densities within it. This could be indicative of a tumor. 2. Air Space Opacification in the Right Upper Lobe (RUL) Finding: There is patchy air space opacification with interlobular septal thickening in the posterior segment of RUL. This could represent infection, inflammation, or more concerningly, metastatic disease or lung cancer causing these changes. 3. Left-sided Pleural Effusion and Subsegmental Atelectasis Pleural Effusion: Mild left-sided pleural effusion is noted. Pleural effusion can occur in the context of metastatic disease or cancer. Atelectasis: This refers to partial lung collapse, which may occur when there is a mass obstructing the airflow or due to pleural fluid. 4. Enlarged Mediastinal and Hilar Lymph Nodes Lymphadenopathy: There are multiple enlarged and necrotic lymph nodes, most notably in the right hilar region, with the largest measuring 35 x 25 mm. Enlargement and necrosis of lymph nodes can be a sign of metastatic spread. The presence of enlarged lymph nodes in the mediastinum and hilum is typical of malignancy spreading beyond the primary lung site. 5. Liver Lesion Size: 14 x 13 mm lesion in the right hepatic lobe, which is well-defined and peripherally enhancing. A hypodense lesion could indicate a metastatic tumor, especially since it shows peripheral enhancement, a characteristic of some types of metastases. 6. Skeletal Lesions Multiple Lesions: There are mixed lytic and sclerotic bony lesions, some with soft tissue components. These lesions involve the vertebrae, ribs, glenoids, sternum, sacral ala, iliac bones, and femur. Soft Tissue Components: Some of the lesions, such as those in the ribs and iliac bones, have a soft tissue component, which suggests more advanced involvement, possibly indicating metastases. 7. Other Findings: No signs of emphysema, bronchiectasis, or pneumothorax were noted, which is reassuring as it reduces the likelihood of certain types of lung diseases. The liver, spleen, pancreas, kidneys, urinary bladder, and prostate all appear normal on imaging, which helps to rule out major issues in these organs. Impression: The findings of a heterogeneously enhancing solitary pulmonary nodule in the right lung, with associated hilar and mediastinal lymphadenopathy, along with a hepatic lesion and extensive skeletal involvement (with mixed lytic and sclerotic lesions), strongly raise concern for metastatic disease, most likely originating from the lung. The primary lung cancer is a potential consideration, though other primary sites are also possible. Next Steps: Histopathological correlation: This means a biopsy or tissue sample should be taken from one of the lesions (pulmonary, hepatic, or bone) to confirm whether the lesions are malignant and, if so, to identify the type of cancer. This will help determine the best course of treatment. The overall picture suggests a metastatic malignancy, likely of pulmonary origin, but further investigations and biopsy are essential to establish a definitive diagnosis and treatment plan.

Male | 58

Answered on 8th Mar '25

Read answer

Cancer Hospitals In Other Cities

Top Related Speciality Doctors In Other Cities

Cost Of Related Treatments In Country

Consult